Add Company
Join Now

Attralus Revenue and Competitors

License our Company Data API

Location

$198M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Attralus's estimated annual revenue is currently $6.2M per year.(i)
  • Attralus's estimated revenue per employee is $155,000
  • Attralus's total funding is $198M.

Employee Data

  • Attralus has 40 Employees.(i)
  • Attralus grew their employee count by 3% last year.

Attralus's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
COO, Co-FounderReveal Email/Phone
3
VP, Head Toxicology, Drug Disposition, and PK/PDReveal Email/Phone
4
SVP, CMCReveal Email/Phone
5
Head IT OperationsReveal Email/Phone
6
SVP Clinical DevelopmentReveal Email/Phone
7
Head Corporate DevelopmentReveal Email/Phone
8
Head Human ResourcesReveal Email/Phone
9
Head Program ManagementReveal Email/Phone
10
VP FinanceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Attralus?

keywords:N/A

$198M

Total Funding

40

Number of Employees

$6.2M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Attralus News

2022-03-30 - Positive New Data from Phase 1/2 Trial of AT-01 Presented at ...

Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with...

2022-03-30 - Positive New Data from Phase 1/2 Trial of AT-01 Presented at 2022 American College of Cardiology Annual Scientific Session

SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.4M40-9%N/A
#2
$8.2M405%$200M
#3
$10.4M40-7%N/A
#4
$10M40-9%N/A
#5
$8M405%N/A